Screener
BioMarin Pharmaceuticals BMRN Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Intangible asset amortization | 73,492 | 4,846 | 77,975 | 9,693 |
| Total operating expenses | 878,788 | 548,523 | 1,515,356 | 1,069,775 |
| INCOME FROM OPERATIONS | 110,920 | 276,887 | 240,560 | 500,780 |
| Interest income | 10,480 | 18,827 | 33,040 | 37,840 |
| Interest expense | (63,295) | (2,679) | (78,253) | (5,542) |
| Other income, net | 3,279 | 4,833 | 7,240 | 2,879 |
| INCOME BEFORE INCOME TAXES | 61,384 | 297,868 | 202,587 | 535,957 |
| Provision for income taxes | 16,622 | 57,336 | 52,298 | 109,739 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's interest income?
- BioMarin Pharmaceuticals (BMRN) reported interest income of $10.48M in Q2 2026.
- How has BioMarin Pharmaceuticals's interest income changed year-over-year?
- BioMarin Pharmaceuticals's interest income decreased by 44.3% year-over-year, from $18.83M to $10.48M.
- What is the long-term trend for BioMarin Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's interest income has grown at a 63.5% compound annual growth rate (CAGR), from $10.48M to $74.9M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about BioMarin Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude